Emerald Bioscience Inc (EMBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EMBI | AZN | AMGN | GILD | BMY |
| Company | Emerald Bioscience Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0925 | 198.89 | 354.90 | 139.69 | 61.21 |
| High | 0.1000 | 201.74 | 357.00 | 141.49 | 62.23 |
| Low | 0.0880 | 198.72 | 351.66 | 138.82 | 60.87 |
| Latest | 0.0900 | 201.00 | 353.60 | 141.05 | 61.90 |
| Change | +0.0015 | +3.78 | +1.75 | +1.68 | +1.25 |
| % Change | +1.69% | +1.92% | +0.50% | +1.21% | +2.06% |
| Volume | 6,962,700 | 1,673,593 | 1,489,142 | 3,051,605 | 6,411,758 |
| 20-Day Average Volume | 9,515,021 | 1,842,362 | 2,667,891 | 6,127,757 | 13,574,324 |
| Previous Close | 0.0885 | 197.22 | 351.85 | 139.37 | 60.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0514 | 191.11 | 359.29 | 141.55 | 59.38 |
| 20-Day Raw Stochastic | 65.09% | 94.47% | 23.07% | 44.93% | 91.77% |
| 20-Day Relative Strength | 72.36 | 57.85 | 46.20 | 49.44 | 59.83 |
| Weighted Alpha | -49.22 | +47.15 | +22.24 | +32.93 | +23.48 |
| Today's Opinion | 32% Buy | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Previous Opinion | 24% Buy | 72% Buy | 40% Buy | 40% Buy | 96% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +119.51% since 01/08/21 | +7.23% since 03/25/26 | -0.24% since 03/25/26 | +1.87% since 03/25/26 | +4.76% since 03/25/26 |
| Low | 0.0400 on 01/11/21 | 182.79 on 03/26/26 | 347.11 on 03/31/26 | 133.89 on 03/30/26 | 58.37 on 03/27/26 |
| High | 0.1195 on 01/13/21 | 201.74 on 04/01/26 | 356.94 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +166.27% since 12/15/20 | -3.73% since 02/27/26 | -9.04% since 02/27/26 | -5.44% since 02/27/26 | -1.00% since 02/27/26 |
| Low | 0.0327 on 12/16/20 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.1195 on 01/13/21 | 206.30 on 03/02/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +114.29% since 10/15/20 | +9.14% since 12/31/25 | +7.87% since 12/31/25 | +14.75% since 12/31/25 | +14.47% since 12/31/25 |
| Low | 0.0245 on 12/09/20 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.1195 on 01/13/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -27.94% since 07/15/20 | +18.94% since 10/01/25 | +18.28% since 10/01/25 | +26.72% since 10/01/25 | +30.18% since 10/01/25 |
| Low | 0.0245 on 12/09/20 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.1270 on 07/16/20 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 24,127 | 305,870,048 | 189,671,072 | 172,989,120 | 123,831,232 |
| Shares Outstanding, K | 268,074 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 1,050,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.43 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/19/21 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.17 | 15.97 | 16.73 | 9.71 |